Controlling blood circulation, biodistribution and tissue accessibility of nanomedicines is key to their clinical translation. In this Review, bioengineering strategies to overcome gatekeeping barriers and promote the targeting, safety and efficacy of nanomedicines are discussed.
- Horacio Cabral
- Junjie Li
- Kazunori Kataoka